These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17972819)

  • 1. [Mechanisms of progression of renal disease--part I (cellular biology)].
    Popović-Polović M
    Srp Arh Celok Lek; 1994; 122(3-4):93-5. PubMed ID: 17972819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The progression of renal disease.
    Klahr S; Schreiner G; Ichikawa I
    N Engl J Med; 1988 Jun; 318(25):1657-66. PubMed ID: 3287163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanisms of the progression of renal disease (risk factors)--part II].
    Popović-Rolović M
    Srp Arh Celok Lek; 1994; 122(7-8):231-3. PubMed ID: 17974395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular structures and lipids in progressive renal disease.
    Moorhead JF; Wheeler DC; Varghese Z
    Am J Med; 1989 Nov; 87(5N):12N-20N. PubMed ID: 2486539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of progression of renal disease: growth factors and related mechanisms.
    Benigni A; Remuzzi G
    J Hypertens Suppl; 1998 Sep; 16(4):S9-12. PubMed ID: 9817186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological intervention in renal fibrosis and vascular sclerosis.
    Becker GJ; Perkovic V; Hewitson TD
    J Nephrol; 2001; 14(5):332-9. PubMed ID: 11730265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of autophagy for glomerular aging and disease.
    Weide T; Huber TB
    Cell Tissue Res; 2011 Mar; 343(3):467-73. PubMed ID: 21286756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New rat model induced by anti-glomerular basement membrane antibody shows severe glomerular adhesion in early stage and quickly progresses to end-stage renal failure.
    Nakano Y; Hirano T; Uehara K; Nishibayashi S; Hattori K; Aihara M; Yamada Y
    Pathol Int; 2008 Jun; 58(6):361-70. PubMed ID: 18477215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesangial Cells and Renal Fibrosis.
    Zhao JH
    Adv Exp Med Biol; 2019; 1165():165-194. PubMed ID: 31399966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microalbuminuria--a biomarker of renal microvascular disease.
    Futrakul N; Sridama V; Futrakul P
    Ren Fail; 2009; 31(2):140-3. PubMed ID: 19212911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation in renal atherosclerotic disease.
    Udani SM; Dieter RS
    Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):873-81. PubMed ID: 18570624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and evolution of atubular glomeruli in the progression of renal disorders.
    Chevalier RL; Forbes MS
    J Am Soc Nephrol; 2008 Feb; 19(2):197-206. PubMed ID: 18199796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microvascular disease and renal disease progression.
    Futrakul N; Futrakul P
    J Med Assoc Thai; 2004 Jul; 87(7):854-9. PubMed ID: 15521246
    [No Abstract]   [Full Text] [Related]  

  • 15. The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat.
    Vogelbacher R; Wittmann S; Braun A; Daniel C; Hugo C
    Transplantation; 2007 Dec; 84(11):1492-9. PubMed ID: 18091526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intrauterine growth restriction and renal function--a long-term problem?].
    Dötsch J; Plank C
    Gynakol Geburtshilfliche Rundsch; 2009; 49(1):8-12. PubMed ID: 19204397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disturbances of glomerular hemodynamics: a risk factor determing progression of glomerular diseases?
    Oite T; Yao J
    J Nephrol; 2009; 22(2):196-202. PubMed ID: 19384836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The danger control concept in kidney disease: mesangial cells.
    Migliorini A; Ebid R; Scherbaum CR; Anders HJ
    J Nephrol; 2013; 26(3):437-49. PubMed ID: 23475470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the glomerular density and size in serial renal biopsies during the progression of IgA nephropathy.
    Tsuboi N; Kawamura T; Ishii T; Utsunomiya Y; Hosoya T
    Nephrol Dial Transplant; 2009 Mar; 24(3):892-9. PubMed ID: 18922859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin inhibits PAI-1 expression and reduces interstitial fibrosis and glomerulosclerosis in chronic allograft nephropathy.
    Pontrelli P; Rossini M; Infante B; Stallone G; Schena A; Loverre A; Ursi M; Verrienti R; Maiorano A; Zaza G; Ranieri E; Gesualdo L; Ditonno P; Bettocchi C; Schena FP; Grandaliano G
    Transplantation; 2008 Jan; 85(1):125-34. PubMed ID: 18192922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.